Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agios Pharmaceuticals (AGIO) Shares Outstanding (Diluted Average): 2019-2024

Historic Shares Outstanding (Diluted Average) for Agios Pharmaceuticals (AGIO) over the last 6 years, with Dec 2024 value amounting to $57.9 million.

  • Agios Pharmaceuticals' Shares Outstanding (Diluted Average) fell 0.50% to $58.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.1 million, marking a year-over-year decrease of 0.50%. This contributed to the annual value of $57.9 million for FY2024, which is 4.02% up from last year.
  • Latest data reveals that Agios Pharmaceuticals reported Shares Outstanding (Diluted Average) of $57.9 million as of FY2024, which was up 4.02% from $55.7 million recorded in FY2023.
  • In the past 5 years, Agios Pharmaceuticals' Shares Outstanding (Diluted Average) ranged from a high of $69.0 million in FY2020 and a low of $54.8 million during FY2022.
  • Over the past 3 years, Agios Pharmaceuticals' median Shares Outstanding (Diluted Average) value was $55.7 million (recorded in 2023), while the average stood at $56.1 million.
  • Per our database at Business Quant, Agios Pharmaceuticals' Shares Outstanding (Diluted Average) increased by 15.01% in 2020 and then dropped by 12.39% in 2021.
  • Yearly analysis of 5 years shows Agios Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $69.0 million in 2020, then fell by 12.39% to $60.4 million in 2021, then dropped by 9.36% to $54.8 million in 2022, then rose by 1.57% to $55.7 million in 2023, then rose by 4.02% to $57.9 million in 2024.